Results 41 to 50 of about 761 (228)
Business Ethics, the Environment &Responsibility, EarlyView.ABSTRACT Can AI‐driven capitalism sustain the moral preconditions of market order? We stage a dialogue between Adam Smith and a steel‐manned “EconAI” to test four Moral‐Market‐Fitness criteria: trustworthiness, fairness, non‐domination, and contestability, across 11 dilemmas.
Alexandra‐Codruța Bîzoi +1 more
wiley +1 more source
Corporate Lobbying as Anticompetitive Behaviour in the EU
European Law Journal, EarlyView.ABSTRACT Despite the influence of ordoliberalism in EU law, the mutual feedback between market power and political influence of dominant corporations has not become an explicit consideration in competition law enforcement and has remained rather in the background as an implicit rationale. If the threats to competition posed by regulatory capture are to
Francisco E. Beneke Avila
wiley +1 more source
Economic Dependence: A New Frontier in EU Competition Law?
European Law Journal, EarlyView.ABSTRACT This paper argues for the recognition of economic dependence as a relevant concept within EU competition law, moving beyond the traditional—yet limited—dominance‐based framework of Article 102 TFEU. Comparative analysis shows that this, or an equivalent concept, is already embedded in the domestic competition regimes of several EU Member ...
Jimena Tamayo Velasco
wiley +1 more source
Access to Documents in Antitrust Litigation – EU and Croatian Perspective [PDF]
Yearbook of Antitrust and Regulatory Studies, 2015 The paper analyses access to documents in cartel-based damages cases from the EU and Croatian perspective. It considers all relevant EU and Croatian legislation and case-law primarily focusing on the expected impact of the newly enacted Damages Directive.
Vlatka Butorac Malnar
doaj +1 more source
From Open Banking Regulation to Platform Orchestration: The Evolution of Digital Platform Governance
Information Systems Journal, EarlyView.ABSTRACT This study contributes to information systems (IS) scholarship by extending platform governance theory to regulatory contexts, explaining how regulatory forces co‐evolve with technological architectures to shape openness and control. This research examines the evolution of platform governance in the context of open banking, where regulatory ...
Priyadharshini Muthukannan +3 more
wiley +1 more source
Protecting Intermediate Innovations When Ideas Are Scarce: Patents or Secrecy?
Journal of Economics &Management Strategy, EarlyView.ABSTRACT Patenting an intermediate research innovation can lead to competition for the development of a final commercial innovation and potentially induce wasteful duplicative R&D efforts. This study examines the effects of different protection strategies and patent life on the incentives to protect an intermediate innovation by considering a two‐stage
Bonwoo Koo, Jangho Yang, Brian D. Wright
wiley +1 more source
We Value Your Privacy: Behavior‐Based Pricing Under Endogenous Privacy
Journal of Economics &Management Strategy, EarlyView.ABSTRACT We study a duopoly model of behavior‐based pricing in which consumers can either disclose or hide their data. We contrast two data policies. Under an open data policy, disclosed data is shared with all firms. In the unique equilibrium, all consumers disclose, and firms price discriminate, leading to welfare losses from inefficient poaching ...
Friederike Heiny +2 more
wiley +1 more source
Competition Enforcement and Accounting for Intangible Capital
The Journal of Finance, EarlyView.ABSTRACT Antitrust laws mandate review of mergers and acquisitions (M&As) that exceed an asset size threshold based on accounting standards that exclude most intangible capital. We show that this exclusion leads to thousands of intangible‐intensive M&As being nonreportable. Acquirers in nonreportable deals achieve higher equity values and price markups,
JOHN D. KEPLER +2 more
wiley +1 more source
The Determinants of Negotiated Pharmaceutical Prices
The Journal of Industrial Economics, EarlyView.ABSTRACT We focus on the determinants of pharmaceutical drug prices. Using data from the Brazilian pharmaceutical market, we find large variations in drug prices across buyers, drug classes, and time periods. Our estimation results provide evidence that transaction‐specific determinants between buyers and sellers (e.g., transaction volume, buyer's ...
Ralph B. Siebert +2 more
wiley +1 more source
Market and Competition Law Review, 2018 Directive 2014/104/EU contains detailed provisions related to the disclosure of evidence in actions for damages before national courts that seek to strike a balance between a claimant’s right to access evidence in support of its private damages claim ...
Claudia Massa
doaj +1 more source